Navigation Links
NCI renewal grant to develop new cancer therapies
Date:12/4/2007

Richmond, Va. (Dec. 4, 2007) – A Virginia Commonwealth University Massey Cancer Center research team has received a renewal grant totaling nearly $1.3 million from the National Cancer Institute to improve the activity of a novel class of agents, known as histone deacetylase inhibitors, in the treatment of leukemia and other blood malignancies.

Through the five-year grant, Steven Grant, M.D., Massey's associate director for translational research and co-leader of the cancer center's cancer cell biology program, and his research team will focus efforts to support ongoing basic and clinical research.

Histone deacetylase inhibitors represent a diverse group of agents that modify the structure of chromatin, and by extension, genes involved in the control of death and differentiation in cancer cells. Chromatin houses the genome and is composed of DNA and scaffolding proteins, notably histones.

However, histone deacetylase inhibitors acetylate other proteins and exert multiple other effects which trigger apoptosis, or programmed cell death, in tumor cells. Acetylation is a chemical reaction that can change the molecular properties of certain proteins.

"Histone deacetylase inhibitors are currently the focus of intense interest as so-called ‘epigenetic agents,' that is, agents that act by modulating gene expression," said Grant, who is also the primary investigator for the project.

"Our goal is to exploit recent insights into the mode of action of these agents to make them even more effective in various hematologic malignancies by rationally combining them with other molecularly targeted agents," he said.

Recently, histone deacetylase inhibitors have been approved for the treatment of patients with cutaneous T cell lymphoma, a type of cancer of the immune system. In previous work, Grant's team has shown that histone deacetylase inhibitors induce acetylation and activation of a transcription factor, NF-kappaB, which
'/>"/>

Contact: Sathya Achia-Abraham
sbachia@vcu.edu
804-827-0890
Virginia Commonwealth University
Source:Eurekalert

Page: 1 2

Related biology news :

1. UCs NIH grant brings technology from outer space to playgrounds
2. Seattle Childrens Hospital leads $23.7 million NIH grant to study gene repair
3. Homeland Security awards 2 grants to Rutgers for nuclear threat detection
4. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
5. UGA Odum School of Ecology professor receives grant to study West Nile Virus in NYC
6. Genes and environment grant funds close look at nature-nurture overlap in common diseases
7. Mustafa alAbsi Ph.D. and national team awarded major NIH grant
8. NIH awards UC $9 million grant to improve patient point-of-care technologies
9. UAB wins $5.7M neurofibromatosis grant
10. Flu vaccine in painless skin patches under development at Emory, Georgia Tech with NIH grants
11. Study reveals that immigrant teenagers eat better than Spanish teenagers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... co-workers discovered that specific types of human papillomavirus (HPV) ... pathogens cause cells to degenerate. It is known today ... E7. Both proteins switch off different cellular control functions, ... Rsl and his co-workers at DKFZ have now discovered ...
(Date:12/3/2009)... the CTRC-AACR San Antonio Breast Cancer Symposium continues to ... leaders from industry and academia with the goal of ... 8,500 scientists and other professionals will gather at the ... Dec. 9-13, 2009. The symposium is a partnership between ...
(Date:12/3/2009)... design of the upcoming forest deal at Copenhagen in order ... the University of Leeds. , Writing today in ... of the carbon credit payments to be agreed at Copenhagen, ... be made to forest dwellers directly, and their property rights ...
Breaking Biology News(10 mins):Papillomavirus silences innate immune response 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology 13776 1Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology 13776 2Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology 13776 3St Lukes Episcopal Hospital First in Houston to Offer Revolutionary Noninvasive Tumor Treatment 55891 1St Lukes Episcopal Hospital First in Houston to Offer Revolutionary Noninvasive Tumor Treatment 55891 2St Lukes Episcopal Hospital First in Houston to Offer Revolutionary Noninvasive Tumor Treatment 55891 3Increasing Health Center Capacity by 20 Million Patients Could Save More Than 24200 Billion Over the Next Decade 55888 1Increasing Health Center Capacity by 20 Million Patients Could Save More Than 24200 Billion Over the Next Decade 55888 2Increasing Health Center Capacity by 20 Million Patients Could Save More Than 24200 Billion Over the Next Decade 55888 3
... popular smoking cessation drug dramatically reduced the amount a ... Medicine study has found.,Heavy-drinking smokers in a laboratory setting ... drug varenicline compared to those taking a placebo, according ... Biological Psychiatry . , The group taking varenicline, sold ...
... their apparent ability to store fat more efficiently than ... has long been suspected that female sex hormones are responsible, ... for the first time drawn a link between one hormone ... childbearing. , On average, women have 6 to 11 percent ...
... origami", the way that proteins fold is vital to ... of Leeds have discovered this is a ,hit and ... before they form the correct structure for their intended ... functions and play a crucial role in the growth, ...
Other Biology News:1 drug may help people both lay down the drink and put out the cigarette 2Why do women store fat differently from men? 2Unfolding 'nature's origami' 2
(Date:12/3/2009)... Nikon Corporation, an innovator of advanced optical instruments, ... agreement with Harvard University granting Nikon the rights ... technology. Under the terms of the agreement, Nikon ... them with the N-STORM name. ,, Nikon ...
(Date:12/3/2009)... Inc. (Nasdaq: PPHM ) today announced that it will ... year 2010 on December 10, 2009 at 7:00 a.m. EST ... the results at 11:30 a.m. EST on the same day. ... second quarter ended October 31, 2009 and will review recent ...
(Date:12/2/2009)... MATK ) announced today that it intends to release ... on December 16, 2009, at approximately 4:00 p.m. Eastern Time ... will conduct a conference call to discuss these results with ... live via webcast by visiting Martek,s web site at ...
(Date:12/2/2009)... Reportlinker.com announces that a new market ... ,, Drug Discovery Technologies - A ... ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ,, Drug ... element of every pharmaceutical company,s business strategy. ...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
... AutoImmune Inc. (OTC,Pink Sheets: AIMM) today reported a net loss ... three months ended June 30, 2008, compared with,a net loss ... for the,three months ended June 30, 2007. For the six ... $0.01 per share basic and diluted, compared,with net loss of ...
... Campbell Alliance, the leading,management consulting firm specializing in ... Naeymi-Rad has been appointed Chief,Operating Officer. His former ... head of the firm,s Brand Management Practice will ... This new senior executive management role for ...
... Campbell Alliance, the leading,management consulting firm specializing ... Darius Naigamwalla has been appointed Senior,Vice President and ... replaces Nader Naeymi-Rad, who was recently promoted to ... has been a member of the Brand Management ...
Other Biology Technology:AutoImmune Inc. Reports 2008 Second Quarter Financial Results 2AutoImmune Inc. Reports 2008 Second Quarter Financial Results 3Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance 2Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance 3Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance 2
... a cocktail of 3 siRNAs specifically targeted ... most popular product. The siTrio reagent guarantees ... your target gene when used under standard ... confirmation of optimal transfection with one of ...
... a compact benchtop and stackable multi-function ... with a large display screen to ... Air circulation inside to evenly distribute ... be easily calibrated from the microprocessor ...
... Nonanoyl-N-methylglucamide ... properties. Can be readily removed by ... Purity: ≥98% by HPLC. ... nm): 2 O. CMC 19 ...
...
Biology Products: